PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma-Reference-Cited by-同舟云学术

PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma

Published:2018-01-30 Issue:17 Volume:37 Page:2213-2224
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Ghannam-Shahbari Dima,Jacob Eyal,Kakun Reli Rachel,Wasserman Tanya,Korsensky Lina,Sternfeld Ofir,Kagan Juliana,Bublik Debora Rosa,Aviel-Ronen Sarit,Levanon Keren^ORCID,Sabo Edmond,Larisch Sarit,Oren Moshe,Hershkovitz Dov,Perets Ruth

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-017-0040-z.pdf

Reference60 articles.

1. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;195:451–6.

2. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230–6.

3. Perets R, Drapkin R. It’s totally tubular….riding the new wave of ovarian cancer research. Cancer Res. 2015;76:10–7.

4. Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104:331–7.

5. Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 2002;18:41–7.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome;Neoplasia;2023-02

2. Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM;Cell Reports Methods;2023-01

3. PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far;OncoTargets and Therapy;2022-10

4. PAX8 in the Junction between Development and Tumorigenesis;International Journal of Molecular Sciences;2022-07-03

5. Identifying key multifunctional components shared by critical cancer and normal liver pathways via sparseGMM;2022-05-16